{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T11:24:19Z","timestamp":1793618659534,"version":"4.5.0"},"reference-count":104,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"33","license":[{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,15]]},"abstract":"<jats:p>Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as nonalcoholic fatty liver disease (NAFLD), is characterized by systemic insulin resistance and metabolic dysfunction. MASLD\/NAFLD elevates the risk of developing cardiovascular disease (CVD). As a quantitative method, bibliometric analysis, illuminates the trajectory of research within a particular field and offers insights into its current state and future directions. In the present study, Citespace (version 6.3.1) was used to comprehensively review the relevant literature for a detailed characterization of the association between MASLD\/NAFLD and CVD. This analysis aimed to delineate the historical progression, current research hotspots, and future development trends of MASLD\/NAFLD and its relationship with CVD. Our findings highlight a notable surge in research interest in MASLD\/NAFLD and CVD over the past 19 years, reflecting an increasing depth of exploration into their interrelationship. In addition to established factors, such as alanine aminotransferase (ALT) and metabolic syndrome, previously overlooked aspects, such as inflammation, gut microbiota, and oxidative stress, have gained significant attention as notable contributors to the pathogenesis of MASLD\/NAFLD. By elucidating the intricate association between MASLD\/NAFLD and CVD, this study provides prospects for pathophysiological mechanism and preventive strategies for both conditions and provides research insights regarding potential future avenues and focal areas for future investigations.<\/jats:p>","DOI":"10.1097\/md.0000000000043952","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T19:00:50Z","timestamp":1755543650000},"page":"e43952","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Association between metabolic dysfunction-associated steatotic liver disease and cardiovascular disease: New perspectives"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1724-870X","authenticated-orcid":false,"given":"Qinyi","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Cardiology, The Affiliated Nanhua Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China"},{"name":"Institute of Cardiovascular Disease, Key Laboratory for Arteriosclerology of Hunan Province, Hunan International Scientific and Technological Cooperation Base of Arteriosclerotic Disease, University of South China, Hengyang, Hunan,China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, The Affiliated Nanhua Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Affiliated Nanhua Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Disease, Key Laboratory for Arteriosclerology of Hunan Province, Hunan International Scientific and Technological Cooperation Base of Arteriosclerotic Disease, University of South China, Hengyang, Hunan,China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaobing","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Affiliated Nanhua Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zili","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Affiliated Nanhua Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3242-0423","authenticated-orcid":false,"given":"Xiaofeng","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Affiliated Nanhua Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260911","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature.","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"key":"R2-20260911","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S2468-1253(21)00020-0","article-title":"Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach.","volume":"6","author":"Targher","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R3-20260911","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","article-title":"Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases.","volume":"66","author":"Adams","year":"2017","journal-title":"Gut"},{"key":"R4-20260911","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.jhep.2021.08.012","article-title":"Epidemiology and risk-stratification of NAFLD-associated HCC.","volume":"75","author":"Ioannou","year":"2021","journal-title":"J Hepatol"},{"key":"R5-20260911","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1016\/j.jhep.2023.08.026","article-title":"99% of patients with NAFLD meet MASLD criteria and natural history is therefore identical.","volume":"80","author":"Hagstr\u00f6m","year":"2024","journal-title":"J Hepatol"},{"key":"R6-20260911","doi-asserted-by":"crossref","first-page":"589","DOI":"10.5009\/gnl210256","article-title":"Metabolic dysfunction-associated fatty liver disease better predicts incident cardiovascular disease.","volume":"16","author":"Jeong","year":"2022","journal-title":"Gut Liver"},{"key":"R7-20260911","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","article-title":"NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications.","volume":"69","author":"Targher","year":"2020","journal-title":"Gut"},{"key":"R8-20260911","doi-asserted-by":"crossref","first-page":"102420","DOI":"10.1016\/j.jceh.2024.102420","article-title":"Comparison of NAFLD, MAFLD, and MASLD prevalence and clinical characteristics in Asia adults.","volume":"15","author":"Huang","year":"2025","journal-title":"J Clin Exp Hepatol"},{"key":"R9-20260911","doi-asserted-by":"crossref","first-page":"102292","DOI":"10.1016\/j.eclinm.2023.102292","article-title":"Metabolic dysfunction-associated steatotic liver disease increases the risk of incident cardiovascular disease: a nationwide cohort study.","volume":"65","author":"Moon","year":"2023","journal-title":"EClinicalMedicine"},{"key":"R10-20260911","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/JPER.17-0319","article-title":"Periodontal disease and its connection to systemic biomarkers of cardiovascular disease in young American Indian\/Alaskan natives.","volume":"89","author":"Delange","year":"2018","journal-title":"J Periodontol"},{"key":"R11-20260911","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1161\/ATV.0000000000000153","article-title":"Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the American Heart Association.","volume":"42","author":"Duell","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R12-20260911","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1136\/gutjnl-2021-325724","article-title":"Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort.","volume":"71","author":"Simon","year":"2022","journal-title":"Gut"},{"key":"R13-20260911","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s12072-023-10543-8","article-title":"An international multidisciplinary consensus statement on MAFLD and the risk of CVD.","volume":"17","author":"Zhou","year":"2023","journal-title":"Hepatol Int"},{"key":"R14-20260911","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.maturitas.2021.05.002","article-title":"At the heart of the matter: cardiovascular health challenges among incarcerated women.","volume":"149","author":"Grammatikopoulou","year":"2021","journal-title":"Maturitas"},{"key":"R15-20260911","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13075-023-03140-5","article-title":"Clinical prediction models of rheumatoid arthritis and its complications: focus on cardiovascular disease and interstitial lung disease.","volume":"25","author":"Shao","year":"2023","journal-title":"Arthritis Res Ther"},{"key":"R16-20260911","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/annrheumdis-2017-211735","article-title":"Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis.","volume":"77","author":"Crowson","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R17-20260911","doi-asserted-by":"crossref","first-page":"110774","DOI":"10.1016\/j.intimp.2023.110774","article-title":"Disruption of Histamine-H(1)R signaling exacerbates cardiac microthrombosis after periodontal disease via TLR4\/NF\u03baB-p65 pathway.","volume":"123","author":"Yang","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"R18-20260911","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases.","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"R19-20260911","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"R20-20260911","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R21-20260911","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","article-title":"Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis.","volume":"65","author":"Targher","year":"2016","journal-title":"J Hepatol"},{"key":"R22-20260911","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMra0912063","article-title":"Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.","volume":"363","author":"Targher","year":"2010","journal-title":"N Engl J Med"},{"key":"R23-20260911","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1210\/jc.2015-1966","article-title":"High prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and normal plasma aminotransferase levels.","volume":"100","author":"Portillo-Sanchez","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"R24-20260911","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1440-1746.2012.07264.x","article-title":"Influence of non-alcoholic fatty liver disease on the development of diabetes mellitus.","volume":"28","author":"Kasturiratne","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"R25-20260911","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1007\/s10620-013-2743-5","article-title":"Predictors of all-cause mortality and liver-related mortality in patients with non-alcoholic fatty liver disease (NAFLD).","volume":"58","author":"Stepanova","year":"2013","journal-title":"Dig Dis Sci"},{"key":"R26-20260911","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement.","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"R27-20260911","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease.","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"R28-20260911","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S2468-1253(21)00308-3","article-title":"Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis.","volume":"6","author":"Mantovani","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R29-20260911","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3350\/cmh.2023.0485","article-title":"Global incidence of adverse clinical events in non-alcoholic fatty liver disease: a systematic review and meta-analysis.","volume":"30","author":"Le","year":"2024","journal-title":"Clin Mol Hepatol"},{"key":"R30-20260911","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/hep4.1700","article-title":"A dynamic aspartate-to-alanine aminotransferase ratio provides valid predictions of incident severe liver disease.","volume":"5","author":"\u00c5berg","year":"2021","journal-title":"Hepatol Commun"},{"key":"R31-20260911","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/hep.25656","article-title":"Mathematical modeling of liver injury and dysfunction after acetaminophen overdose: early discrimination between survival and death.","volume":"56","author":"Remien","year":"2012","journal-title":"Hepatology"},{"key":"R32-20260911","doi-asserted-by":"crossref","first-page":"e25901","DOI":"10.1002\/jia2.25901","article-title":"Prevalence of cardiovascular risk factors by HIV status in a population-based cohort in South Central Uganda: a cross-sectional survey.","volume":"25","author":"Enriquez","year":"2022","journal-title":"J Int AIDS Soc"},{"key":"R33-20260911","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2337\/diacare.26.3.725","article-title":"The diabetes risk score: a practical tool to predict type 2 diabetes risk.","volume":"26","author":"Lindstr\u00f6m","year":"2003","journal-title":"Diabetes Care"},{"key":"R34-20260911","doi-asserted-by":"crossref","first-page":"e26693","DOI":"10.1097\/MD.0000000000026693","article-title":"The association between AST\/ALT ratio and all-cause and cardiovascular mortality in patients with hypertension.","volume":"100","author":"Liu","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"R35-20260911","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/MEG.0000000000001353","article-title":"Elevated liver enzymes and cardiovascular mortality: a systematic review and dose-response meta-analysis of more than one million participants.","volume":"31","author":"Rahmani","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R36-20260911","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.atherosclerosis.2014.06.006","article-title":"Liver enzymes and risk of cardiovascular disease in the general population: a meta-analysis of prospective cohort studies.","volume":"236","author":"Kunutsor","year":"2014","journal-title":"Atherosclerosis"},{"key":"R37-20260911","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1161\/01.CIR.0000112379.88385.67","article-title":"Clinical management of metabolic syndrome: report of the American Heart Association\/National Heart, Lung, and Blood Institute\/American Diabetes Association conference on scientific issues related to management.","volume":"109","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"R38-20260911","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/1753944717711379","article-title":"Metabolic syndrome: pathophysiology, management, and modulation by natural compounds.","volume":"11","author":"Rochlani","year":"2017","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"R39-20260911","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1042\/CS20030285","article-title":"Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients.","volume":"106","author":"Videla","year":"2004","journal-title":"Clin Sci (Lond)"},{"key":"R40-20260911","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1161\/CIRCRESAHA.116.309326","article-title":"Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis.","volume":"120","author":"F\u00f6rstermann","year":"2017","journal-title":"Circ Res"},{"key":"R41-20260911","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1590\/1806-9282.63.01.85","article-title":"The role of oxidative stress on the pathophysiology of metabolic syndrome.","volume":"63","author":"Francisqueti","year":"2017","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"R42-20260911","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1016\/j.ijcard.2013.01.278","article-title":"Mechanisms of oxidative stress in human aortic aneurysms--association with clinical risk factors for atherosclerosis and disease severity.","volume":"168","author":"Guzik","year":"2013","journal-title":"Int J Cardiol"},{"key":"R43-20260911","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13023-014-0123-7","article-title":"Oxidative stress-dependent activation of collagen synthesis is induced in human pulmonary smooth muscle cells by sera from patients with scleroderma-associated pulmonary hypertension.","volume":"9","author":"Boin","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"R44-20260911","doi-asserted-by":"crossref","first-page":"H24","DOI":"10.1152\/ajpheart.00799.2009","article-title":"Direct evidence of a role for Nox2 in superoxide production, reduced nitric oxide bioavailability, and early atherosclerotic plaque formation in ApoE-\/- mice.","volume":"298","author":"Judkins","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R45-20260911","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.bbrc.2012.11.066","article-title":"SIRT3 protects cardiomyocytes from oxidative stress-mediated cell death by activating NF-\u03baB.","volume":"430","author":"Chen","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"R46-20260911","doi-asserted-by":"crossref","first-page":"6382","DOI":"10.3390\/ijms24076382","article-title":"The role of oxidative stress enhanced by adiposity in cardiometabolic diseases.","volume":"24","author":"\u015awi\u0105tkiewicz","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R47-20260911","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3390\/antiox13010087","article-title":"The intersection of genetic factors, aberrant nutrient metabolism and oxidative stress in the progression of cardiometabolic disease.","volume":"13","author":"Butcko","year":"2024","journal-title":"Antioxidants (Basel)"},{"key":"R48-20260911","doi-asserted-by":"crossref","first-page":"2307568","DOI":"10.1080\/19490976.2024.2307568","article-title":"Gut microbiota-derived indole compounds attenuate metabolic dysfunction-associated steatotic liver disease by improving fat metabolism and inflammation.","volume":"16","author":"Min","year":"2024","journal-title":"Gut Microbes"},{"key":"R49-20260911","doi-asserted-by":"crossref","first-page":"16684","DOI":"10.3390\/ijms242316684","article-title":"Mixture of peanut skin extract, geniposide, and isoquercitrin improves the hepatic lipid accumulation of mice via modification of gut microbiota homeostasis and the TLR4 and AMPK signaling pathways.","volume":"24","author":"Yi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R50-20260911","doi-asserted-by":"crossref","first-page":"14668","DOI":"10.1038\/s41598-023-41160-y","article-title":"Gut commensal Kineothrix alysoides mitigates liver dysfunction by restoring lipid metabolism and gut microbial balance.","volume":"13","author":"Choi","year":"2023","journal-title":"Sci Rep"},{"key":"R51-20260911","doi-asserted-by":"crossref","first-page":"2003176","DOI":"10.1080\/19490976.2021.2003176","article-title":"Combined berberine and probiotic treatment as an effective regimen for improving postprandial hyperlipidemia in type 2 diabetes patients: a double blinded placebo controlled randomized study.","volume":"14","author":"Wang","year":"2022","journal-title":"Gut Microbes"},{"issue":"Suppl 1","key":"R52-20260911","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1073\/pnas.1011383107","article-title":"Human oral, gut, and plaque microbiota in patients with atherosclerosis.","volume":"108","author":"Koren","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R53-20260911","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1056\/NEJMra1600266","article-title":"The human intestinal microbiome in health and disease.","volume":"375","author":"Lynch","year":"2016","journal-title":"N Engl J Med"},{"key":"R54-20260911","doi-asserted-by":"crossref","first-page":"9087","DOI":"10.3390\/ijms24109087","article-title":"Gut microbiota and cardiovascular disease: evidence on the metabolic and inflammatory background of a complex relationship.","volume":"24","author":"Nesci","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R55-20260911","doi-asserted-by":"crossref","first-page":"159559","DOI":"10.1016\/j.bbalip.2024.159559","article-title":"TMAO induces pyroptosis of vascular endothelial cells and atherosclerosis in ApoE(-\/-) mice via MBOAT2-mediated endoplasmic reticulum stress.","volume":"1869","author":"Yu","year":"2024","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"R56-20260911","doi-asserted-by":"crossref","first-page":"e0310","DOI":"10.1097\/HC9.0000000000000310","article-title":"Gut microbiota and metabolic biomarkers in metabolic dysfunction-associated steatotic liver disease.","volume":"8","author":"Long","year":"2024","journal-title":"Hepatol Commun"},{"key":"R57-20260911","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.3390\/nu14132654","article-title":"Gut microbiota-derived metabolites and cardiovascular disease risk: a systematic review of prospective cohort studies.","volume":"14","author":"Sanchez-Gimenez","year":"2022","journal-title":"Nutrients"},{"key":"R58-20260911","doi-asserted-by":"crossref","first-page":"115925","DOI":"10.1016\/j.bcp.2023.115925","article-title":"A novel gene signature to diagnose MASLD in metabolically unhealthy obese individuals.","volume":"218","author":"Meroni","year":"2023","journal-title":"Biochem Pharmacol"},{"key":"R59-20260911","doi-asserted-by":"crossref","first-page":"17174","DOI":"10.3390\/ijms242417174","article-title":"Reduced lipopolysaccharide-binding protein (LBP) levels are associated with non-alcoholic fatty liver disease (NAFLD) and adipose inflammation in human obesity.","volume":"24","author":"Barchetta","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R60-20260911","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3390\/nu16060904","article-title":"Effects of NPY-2 receptor antagonists, semaglutide, PYY(3-36), and empagliflozin on early MASLD in diet-induced obese rats.","volume":"16","author":"Kloock","year":"2024","journal-title":"Nutrients"},{"key":"R61-20260911","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12916-023-02836-4","article-title":"Association between epicardial adipose tissue and incident heart failure mediating by alteration of natriuretic peptide and myocardial strain.","volume":"21","author":"Choy","year":"2023","journal-title":"BMC Med"},{"key":"R62-20260911","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.2967\/jnumed.115.166025","article-title":"Supraclavicular brown adipose tissue 18F-FDG uptake and cardiovascular disease.","volume":"57","author":"Takx","year":"2016","journal-title":"J Nucl Med"},{"key":"R63-20260911","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/jdv.12516","article-title":"Epicardial adipose tissue and coronary artery calcification in psoriasis patients.","volume":"29","author":"Torres","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R64-20260911","doi-asserted-by":"crossref","first-page":"e13875","DOI":"10.1111\/acel.13875","article-title":"Endothelial cell telomere dysfunction induces senescence and results in vascular and metabolic impairments.","volume":"22","author":"Bloom","year":"2023","journal-title":"Aging Cell"},{"key":"R65-20260911","doi-asserted-by":"crossref","first-page":"156724","DOI":"10.1016\/j.cyto.2024.156724","article-title":"Inflammation-related miRNAs in obesity, CVD, and NAFLD.","volume":"182","author":"Aghaei","year":"2024","journal-title":"Cytokine"},{"key":"R66-20260911","doi-asserted-by":"crossref","first-page":"8340257","DOI":"10.1155\/2016\/8340257","article-title":"Pivotal cytoprotective mediators and promising therapeutic strategies for endothelial progenitor cell-based cardiovascular regeneration.","volume":"2016","author":"Kim","year":"2016","journal-title":"Stem Cells Int"},{"issue":"Pt 8","key":"R67-20260911","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1093\/brain\/awn144","article-title":"Parthenogenetic dopamine neurons from primate embryonic stem cells restore function in experimental Parkinson\u2019s disease.","volume":"131","author":"Sanchez-Pernaute","year":"2008","journal-title":"Brain"},{"key":"R68-20260911","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1089\/scd.2015.0157","article-title":"Activation of FGF1B promoter and FGF1 are involved in cardiogenesis through the signaling of PKC, but not MAPK.","volume":"24","author":"Lin","year":"2015","journal-title":"Stem Cells Dev"},{"key":"R69-20260911","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.jhep.2023.05.007","article-title":"Therapeutic opportunities for the treatment of NASH with genetically validated targets.","volume":"79","author":"Lind\u00e9n","year":"2023","journal-title":"J Hepatol"},{"key":"R70-20260911","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/liv.15845","article-title":"Impact of PNPLA3 and TM6SF2 polymorphisms on the prognosis of patients with MASLD and type 2 diabetes mellitus.","volume":"44","author":"Lavrado","year":"2024","journal-title":"Liver Int"},{"key":"R71-20260911","doi-asserted-by":"crossref","first-page":"13406","DOI":"10.3390\/ijms241713406","article-title":"Evaluation of human hepatocyte drug metabolism carrying high-risk or protection-associated liver disease genetic variants.","volume":"24","author":"Faccioli","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R72-20260911","doi-asserted-by":"crossref","first-page":"15046","DOI":"10.3390\/ijms242015046","article-title":"PNPLA3 rs738409 genetic variant inversely correlates with platelet count, thereby affecting the performance of noninvasive scores of hepatic fibrosis.","volume":"24","author":"Meroni","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R73-20260911","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.7150\/thno.87968","article-title":"Metabolite Neu5Ac triggers SLC3A2 degradation promoting vascular endothelial ferroptosis and aggravates atherosclerosis progression in ApoE(-\/-)mice.","volume":"13","author":"Xiang","year":"2023","journal-title":"Theranostics"},{"key":"R74-20260911","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12957-022-02748-2","article-title":"Effects of APOE gene \u03b54 allele on serum lipid profiles and risk of cardiovascular disease and tumorigenesis in southern Chinese population.","volume":"20","author":"Gan","year":"2022","journal-title":"World J Surg Oncol"},{"key":"R75-20260911","doi-asserted-by":"crossref","first-page":"10281","DOI":"10.3390\/ijms241210281","article-title":"Association of CETP gene polymorphisms and haplotypes with cardiovascular risk.","volume":"24","author":"Piko","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R76-20260911","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jacc.2019.05.043","article-title":"Risk of premature atherosclerotic disease in patients with monogenic versus polygenic familial hypercholesterolemia.","volume":"74","author":"Trinder","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"R77-20260911","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00018-018-2943-4","article-title":"An insight into gut microbiota and its functionalities.","volume":"76","author":"Adak","year":"2019","journal-title":"Cell Mol Life Sci"},{"key":"R78-20260911","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11154-019-09512-0","article-title":"Dietary lipids, gut microbiota and lipid metabolism.","volume":"20","author":"Schoeler","year":"2019","journal-title":"Rev Endocr Metab Disord"},{"key":"R79-20260911","doi-asserted-by":"crossref","first-page":"15718","DOI":"10.1073\/pnas.0407076101","article-title":"The gut microbiota as an environmental factor that regulates fat storage.","volume":"101","author":"B\u00e4ckhed","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R80-20260911","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1053\/j.gastro.2012.06.031","article-title":"Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome.","volume":"143","author":"Vrieze","year":"2012","journal-title":"Gastroenterology"},{"key":"R81-20260911","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1161\/CIRCRESAHA.115.306807","article-title":"The gut microbiome contributes to a substantial proportion of the variation in blood lipids.","volume":"117","author":"Fu","year":"2015","journal-title":"Circ Res"},{"key":"R82-20260911","doi-asserted-by":"crossref","first-page":"100987","DOI":"10.1016\/j.jhepr.2023.100987","article-title":"Microbiota modulation by dietary oat beta-glucan prevents steatotic liver disease progression.","volume":"6","author":"Jaeger","year":"2024","journal-title":"JHEP Rep"},{"key":"R83-20260911","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejim.2023.11.025","article-title":"Will the manipulation of the gut microbiota be effective for the treatment of metabolic diseases.","volume":"119","author":"Catal\u00e1n","year":"2024","journal-title":"Eur J Intern Med"},{"key":"R84-20260911","doi-asserted-by":"crossref","first-page":"8536","DOI":"10.1021\/acs.jafc.3c08910","article-title":"Probiotic mixture ameliorates a diet-induced MASLD\/MASH murine model through the regulation of hepatic lipid metabolism and the gut microbiome.","volume":"72","author":"Zhang","year":"2024","journal-title":"J Agric Food Chem"},{"key":"R85-20260911","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1159\/000053693","article-title":"SDF-1 induces IL-8 production and transendothelial migration of human cord blood-derived mast cells.","volume":"124","author":"Lin","year":"2001","journal-title":"Int Arch Allergy Immunol"},{"key":"R86-20260911","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1681\/ASN.2008060640","article-title":"The CXCL12 (SDF-1)\/CXCR4 axis is essential for the development of renal vasculature.","volume":"20","author":"Takabatake","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R87-20260911","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1073\/pnas.0809568106","article-title":"SDF-1alpha stimulates JNK3 activity via eNOS-dependent nitrosylation of MKP7 to enhance endothelial migration.","volume":"106","author":"Pi","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R88-20260911","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0012-1606(02)00080-5","article-title":"Differentiation of nonbeating embryonic stem cells into beating cardiomyocytes is dependent on downregulation of PKC beta and zeta in concert with upregulation of PKC epsilon.","volume":"255","author":"Zhou","year":"2003","journal-title":"Dev Biol"},{"key":"R89-20260911","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00441-010-1024-2","article-title":"Hormone-like (endocrine) Fgfs: their evolutionary history and roles in development, metabolism, and disease.","volume":"342","author":"Itoh","year":"2010","journal-title":"Cell Tissue Res"},{"key":"R90-20260911","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cmet.2021.12.004","article-title":"FGF1 and insulin control lipolysis by convergent pathways.","volume":"34","author":"Sancar","year":"2022","journal-title":"Cell Metab"},{"key":"R91-20260911","doi-asserted-by":"crossref","first-page":"7256","DOI":"10.1038\/s41467-021-27584-y","article-title":"Paracrine FGFs target skeletal muscle to exert potent anti-hyperglycemic effects.","volume":"12","author":"Ying","year":"2021","journal-title":"Nat Commun"},{"key":"R92-20260911","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1440-1746.2008.05544.x","article-title":"Polymorphism of human leptin receptor gene is associated with type 2 diabetic patients complicated with non-alcoholic fatty liver disease in China.","volume":"24","author":"Lu","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"R93-20260911","first-page":"335","article-title":"Lys656Asn polymorphism of leptin receptor, leptin levels and insulin resistance in patients with non alcoholic fatty liver disease.","volume":"16","author":"Aller","year":"2012","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R94-20260911","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0168-8227(03)00163-3","article-title":"Leptin receptor polymorphism is associated with serum lipid levels and impairment of cholesterol lowering effect by simvastatin in Japanese men.","volume":"62","author":"Takahashi-Yasuno","year":"2003","journal-title":"Diabetes Res Clin Pract"},{"key":"R95-20260911","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/sj.ijo.0803234","article-title":"The Gln223Arg polymorphism in the leptin receptor is associated with familial combined hyperlipidemia.","volume":"30","author":"van der Vleuten","year":"2006","journal-title":"Int J Obes (Lond)"},{"key":"R96-20260911","doi-asserted-by":"crossref","first-page":"11403","DOI":"10.3390\/ijms150711403","article-title":"Genetic variants of APOC3 promoter and HLA-B genes in an HIV infected cohort in northern South Africa: a pilot study.","volume":"15","author":"Masebe","year":"2014","journal-title":"Int J Mol Sci"},{"key":"R97-20260911","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1086\/429295","article-title":"Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders.","volume":"191","author":"Tarr","year":"2005","journal-title":"J Infect Dis"},{"key":"R98-20260911","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s001250051607","article-title":"Variable effects of the APOC3-482C > T variant on insulin, glucose and triglyceride concentrations in different ethnic groups.","volume":"44","author":"Waterworth","year":"2001","journal-title":"Diabetologia"},{"key":"R99-20260911","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease.","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat Genet"},{"key":"R100-20260911","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1038\/ncomms5309","article-title":"TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease.","volume":"5","author":"Liu","year":"2014","journal-title":"Nat Commun"},{"key":"R101-20260911","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1002\/hep.28142","article-title":"The dual and opposite role of the TM6SF2-rs58542926 variant in protecting against cardiovascular disease and conferring risk for nonalcoholic fatty liver: a meta-analysis.","volume":"62","author":"Pirola","year":"2015","journal-title":"Hepatology"},{"key":"R102-20260911","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1194\/jlr.D079301","article-title":"Use of next-generation sequencing to detect LDLR gene copy number variation in familial hypercholesterolemia.","volume":"58","author":"Iacocca","year":"2017","journal-title":"J Lipid Res"},{"key":"R103-20260911","doi-asserted-by":"crossref","first-page":"E682","DOI":"10.1002\/humu.21002","article-title":"The molecular basis of familial hypercholesterolemia in Lebanon: spectrum of LDLR mutations and role of PCSK9 as a modifier gene.","volume":"30","author":"Abifadel","year":"2009","journal-title":"Hum Mutat"},{"key":"R104-20260911","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1093\/eurheartj\/ehw028","article-title":"Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217.","volume":"37","author":"Benn","year":"2016","journal-title":"Eur Heart J"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000043952","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:00:55Z","timestamp":1789153255000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000043952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,15]]},"references-count":104,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043952","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,15]]},"assertion":[{"value":"2025-01-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}